share_log

Recursion Pharmaceuticals | 8-K: Current report

Recursion Pharmaceuticals | 8-K: Current report

Recursion Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  06/07 09:01
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. conducted its 2024 annual meeting of stockholders on June 3, 2024. During the meeting, two Class III directors were elected to serve until the 2027 annual meeting. The elected directors are Blake Borgeson, Ph.D., with 165,914,956 votes for and 26,093,759 withheld, and Dean Y. Li, M.D., Ph.D., with 166,211,058 votes for and 25,797,657 withheld. Additionally, an advisory resolution to approve executive compensation was passed with 188,317,831 votes for, 2,887,180 against, and 803,704 abstentions. The details of these proposals and their descriptions were previously filed with the SEC in the definitive Proxy Statement on April 23, 2024. The annual meeting's outcomes were reported in compliance with the SEC regulations.
Recursion Pharmaceuticals, Inc. conducted its 2024 annual meeting of stockholders on June 3, 2024. During the meeting, two Class III directors were elected to serve until the 2027 annual meeting. The elected directors are Blake Borgeson, Ph.D., with 165,914,956 votes for and 26,093,759 withheld, and Dean Y. Li, M.D., Ph.D., with 166,211,058 votes for and 25,797,657 withheld. Additionally, an advisory resolution to approve executive compensation was passed with 188,317,831 votes for, 2,887,180 against, and 803,704 abstentions. The details of these proposals and their descriptions were previously filed with the SEC in the definitive Proxy Statement on April 23, 2024. The annual meeting's outcomes were reported in compliance with the SEC regulations.
Recursion Pharmaceuticals公司於2024年6月3日舉行了2024年股東大會。在會議期間,兩位三類董事會成員當選,並將服務於2027年股東大會。當選的董事是Blake Borgeson博士,獲得了165,914,956票贊成和26,093,759票棄權,以及Dean Y. Li醫學博士,獲得了166,211,058票贊成和25,797,657票棄權。此外,一項關於批准高管薪酬的諮詢性決議獲得了188,317,831票贊成,2,887,180票反對和803,704票棄權。這些提案及其描述的詳細信息已於2024年4月23日在提交給SEC的正式代理聲明中進行了披露。本次年度股東大會的結果符合SEC監管規定。
Recursion Pharmaceuticals公司於2024年6月3日舉行了2024年股東大會。在會議期間,兩位三類董事會成員當選,並將服務於2027年股東大會。當選的董事是Blake Borgeson博士,獲得了165,914,956票贊成和26,093,759票棄權,以及Dean Y. Li醫學博士,獲得了166,211,058票贊成和25,797,657票棄權。此外,一項關於批准高管薪酬的諮詢性決議獲得了188,317,831票贊成,2,887,180票反對和803,704票棄權。這些提案及其描述的詳細信息已於2024年4月23日在提交給SEC的正式代理聲明中進行了披露。本次年度股東大會的結果符合SEC監管規定。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息